Increasing importance of viruses in acute otitis media

Annals of Medicine

Volumn 32, Issue 3, 2000, Pages 157-163

  Heikkinen, Terho ^a   Chonmaitree, Tasnee ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Acute otitis media; Bacteria; Cytokines; Inflammatory mediators; Middle ear; Otitis media; Respiratory tract infection; Viral vaccines; Virus

Indexed keywords

ANTIBIOTIC AGENT; AUTACOID; INFLUENZA VACCINE;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; CHILD; CHINCHILLA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; HOST RESISTANCE; HUMAN; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MIDDLE EAR; NASOPHARYNX; OTITIS MEDIA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VIRUS DETECTION; VIRUS INFECTION;

EID: 0034096659     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853890008998822     Document Type: Review

References (78)

1. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995; 273: 214-9.
2. Froom J, Culpepper L, Grob P, Bartelds A, Bowers P, Bridges-Webb C, et al. Diagnosis and antibiotic treatment of acute otitis media: report from International Primary Care Network. BMJ 1990; 300: 582-6.
3. Wang EEL, Einarson TR, Kellner JD, Conly JM. Antibiotic prescribing for Canadian preschool children: evidence of overprescribing for viral respiratory infections. Clin Infect Dis 1999; 29: 155-60.
4. Shurin PA, Pelton SI, Donner A, Klein JO. Persistence of middle-ear effusion after acute otitis media in children. N Engl J Med 1979; 300: 1121-3.
5. Mandel EM, Bluestone CD, Rockette HE, Blatter MM, Reisinger KS, Wucher FP, et al. Duration of effusion after antibiotic treatment for acute otitis media: comparison of cefaclor and amoxicillin. Pediatr Infect Dis 1982; 1: 310-6.
6. Niemelä M, Uhari M, Möttönen M, Pokka T. Costs arising from otitis media. Acta Paediatr 1999; 88: 553-6.
7. Teele DW, Klein JO, Chase C, Menyuk P, Rosner BA. Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. Greater Boston Otitis Media Study Group. J Infect Dis 1990; 162: 685-94.
8. Luotonen M, Uhari M, Aitola L, Lukkaroinen A-M, Luotonen J, Uhari M, et al. Recurrent otitis media during infancy and linguistic skills at the age of nine years. Pediatr Infect Dis J 1996; 15: 854-8.
9. Chonmaitree T, Howie VM. Bacteriology of otitis media. In: Bernstein JM, Ogra PL, eds. Immunology of the ear. New York, NY: Raven Press; 1987: 231-47.
10. Pukander J, Karma P, Sipilä M. Occurrence and recurrence of acute otitis media among children. Acta Otolaryngol (Stockh) 1982; 94: 479-86.
11. Ruuskanen O, Arola M, Putto-Laurila A, Mertsola J, Meurman O, Viljanen MK, et al. Acute otitis media and respiratory virus infections. Pediatr Infect Dis J 1989; 8: 94-9.
12. Teele DW, Klein JO, Rosner B, and the Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in Greater Boston: a prospective, cohort study. J Infect Dis 1989; 160: 83-94.
13. Wald ER, Dashefsky B, Byers C, Guerra N, Taylor F. Frequency and severity of infections in day care. J Pediatr 1988; 112: 540-6.
14. Daly KA, Brown JE, Lindgren BR, Meland MH, Le CT, Giebink GS. Epidemiology of otitis media onset by six months of age. Pediatrics 1999; 103: 1158-66.
15. Heikkinen T, Ruuskanen O. Temporal development of acute otitis media during upper respiratory tract infection. Pediatr Infect Dis J 1994; 13: 659-61.
16. Koivunen P, Kontiokari T, Niemelä M, Pokka T, Uhari M. Time to development of acute otitis media during an upper respiratory tract infection in children. Pediatr Infect Dis J 1999; 18: 303-5.
17. Henderson FW, Collier AM, Sanyal MA, Watkins JM, Fairclough DL, Clyde WA Jr, et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med 1982; 306: 1377-83.
18. Klein BS, Dollete FR, Yolken RH. The role of respiratory syncytial virus and other viral pathogens in acute otitis media. J Pediatr 1982; 101: 16-20.
19. Sarkkinen H, Ruuskanen O, Meurman O, Puhakka H, Virolainen E, Eskola J. Identification of respiratory virus antigens in middle ear fluids of children with acute otitis media. J Infect Dis 1985; 151: 444-8.
20. Chonmaitree T, Howie VM, Truant AL. Presence of respiratory viruses in middle ear fluids and nasal wash specimens from children with acute otitis media. Pediatrics 1986; 77: 698-702.
21. Arola M, Ziegler T, Ruuskanen O, Mertsola J, Näntö-Salonen K, Halonen P. Rhinovirus in acute otitis media. J Pediatr 1988; 113: 693-5.
22. Arola M, Ziegler T, Ruuskanen O. Respiratory virus infection as a cause of prolonged symptoms in acute otitis media. J Pediatr 1990; 116: 697-701.
23. Arola M, Ruuskanen O, Ziegler T, Mertsola J, Näntö-Salonen K, Putto-Laurila A, et al. Clinical role of respiratory virus infection in acute otitis media. Pediatrics 1990; 86: 848-55.
24. Chonmaitree T, Owen MJ, Patel JA, Hedgpeth D, Horlick D, Howie VM. Effect of viral respiratory tract infection on outcome of acute otitis media. J Pediatr 1992; 120: 856-62.
25. Pitkäranta A, Virolainen A, Jero J, Arruda E, Hayden FG. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics 1998; 102: 291-5.
26. Uhari M, Hietala J, Tuokko H. Risk of acute otitis media in relation to the viral etiology of infections in children. Clin Infect Dis 1995; 20: 521-4.
27. Bluestone CD. Pathogenesis of otitis media: role of eustachian tube. Pediatr Infect Dis J 1996; 15: 281-91.
28. Giebink GS, Berzins IK, Marker SC, Schiffman G. Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect Immun 1980; 30: 445-50.
29. Giebink GS, Ripley ML, Wright PF. Eustachian tube histopathology during experimental influenza A virus infection in the chinchilla. Ann Otol Rhinol Laryngol 1987; 96: 199-206.
30. Suzuki K, Bakaletz LO. Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media. Infect Immun 1994; 62: 1710-8.
31. Sanyal MA, Henderson FW, Stempel EC, Collier AM, Denny FW. Effect of upper respiratory tract infection on eustachian tube ventilatory function in the preschool child. J Pediatr 1980; 97: 11-5.
32. Doyle WJ, McBride TP, Skoner DP, Maddern BR, Gwaltney JM Jr, Uhrin M. A double-blind, placebo-controlled clinical trial of the effect of chlorpheniramine on the response of the nasal airway, middle ear, and eustachian tube to provocative rhinovirus challenge. Pediatr Infect Dis J 1988; 7: 229-38.
33. McBride TP, Doyle WJ, Hayden FG, Gwaltney JM Jr. Alterations of the eustachian tube, middle ear, and nose in rhinovirus infection. Arch Otolaryngol Head Neck Surg 1989; 115: 1054-9.
34. Buchman CA, Doyle WJ, Skoner D, Fireman P, Gwaltney JM. Otologic manifestations of experimental rhinovirus infection. Laryngoscope 1994; 104: 1295-9.
35. Doyle WJ, Skoner DP, Hayden F, Buchman CA, Seroky JT, Fireman P. Nasal and otologic effects of experimental influenza A virus infection. Ann Otol Rhinol Laryngol 1994; 103: 59-69.
36. Buchman CA, Doyle WJ, Skoner DP, Post JC, Alper CM, Seroky JT, et al. Influenza A virus-induced acute otitis media. J Infect Dis 1995; 172: 1348-51.
37. Zhu Z, Tang W, Ray A, Wu Y, Einarsson O, Landry ML, et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. J Clin Invest 1996; 97: 421-30.
38. Welliver RC, Wong DT, Sun M, Middleton E Jr, Vaughan RS, Ogra PL. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981; 305: 841-6.
39. Naclerio RM, Proud D, Lichtenstein LM, Kagey-Sobotka A, Hendley JO, Sorrentino J, et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis 1988; 157: 133-42.
40. Volovitz B, Faden H, Ogra PL. Release of leukotriene C4 in respiratory tract during acute viral infection. J Pediatr 1988; 112: 218-22.
41. Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J, Koren HS, et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 1995; 171: 584-92.
42. Matsuda K, Tsutsumi H, Okamoto Y, Chiba C. Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. Clin Diagn Lab Immun 1995; 2: 322-4.
43. Fritz RS, Hayden FG, Calfee DP, Cass LMR, Peng AW, Alvord WG, et al. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis 1999; 180: 586-93.
44. Doyle WJ, Boehm S, Skoner DP. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol 1990; 86: 924-35.
45. Patel JA, Jiang Z, Nakajima N, Kunimoto M. Autocrine regulation of interleukin-8 by interleukin-1α in respiratory syncytial virus-infected pulmonary epithelial cells in vitro. Immunology 1998; 95: 501-6.
46. Patel J, Faden H, Sharma S, Ogra PL. Effect of respiratory syncytial virus on adherence, colonization and immunity of non-typable Haemophilus influenzae: implications for otitis media. Int J Pediatr Otorhinolaryngol 1992; 23: 15-23.
47. Wadowsky RM, Mietzner SM, Skoner DP, Doyle WJ, Fireman P. Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects. Infect Immun 1995; 63: 1153-7.
48. Jiang Z, Nagata N, Molina E, Bakaletz LO, Hawkins H, Patel JA. Fimbria-mediated enhanced attachment of non-typeable Haemophilus influenzae to respiratory syncytial virus-infected respiratory epithelial cells. Infect Immun 1999; 67: 187-92.
49. Håkansson A, Kidd A, Wadell G, Sabharwal H, Svanborg C. Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae. Infect Immun 1994; 62: 2707-14.
50. Fainstein V, Musher DM, Cate TR. Bacterial adherence to pharyngeal cells during viral infection. J Infect Dis 1980; 141: 172-6.
51. Abramson JS, Wheeler JG. Virus-induced neutrophil dysfunction: role in the pathogenesis of bacterial infections. Pediatr Infect Dis J 1994; 13: 643-52.
52. Abramson JS, Giebink GS, Quie PG. Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media. Infect Immun 1982; 36: 289-96.
53. Sawyer WD. Interaction of influenza virus with leukocytes and its effect on phagocytosis. J Infect Dis 1969; 119: 541-56.
54. Ruutu T, Kosunen TU. Phagocytic activity of neutrophilic leukocytes of A2 influenza patients. Acta Pathol Microbiol Scand 1971; 79: 67-72.
55. Larson HE, Blades R. Impairment of human polymorpho-nuclear leucocyte function by influenza virus. Lancet 1976; i: 283.
56. Ruuskanen O, Ogra PL. Respiratory syncytial virus. Curr Probl Pediatr 1993; 23: 50-79.
57. Hsia J, Goldstein AL, Simon GL, Sztein M, Hayden FG. Peripheral blood mononuclear cell interleukin-2 and interferon-gamma production, cytotoxicity, and antigen-stimulated blastogenesis during experimental rhinovirus infection. J Infect Dis 1990; 162: 591-7.
58. Skoner DP, Whiteside TL, Wilson JW, Doyle WJ, Herberman RB, Fireman P. Effect of rhinovirus 39 infection on cellular immune parameters in allergic and nonallergic subjects. J Allergy Clin Immunol 1993; 92: 732-43.
59. Berglund B, Salmivalli A, Grönroos JA. The role of respiratory syncytial virus in otitis media in children. Acta Otolaryngol (Stockh) 1967; 63: 445-54.
60. Tilles JG, Klein JO, Jao RL, Haslam JE Jr, Feingold M, Gellis SS, et al. Acute otitis media in children: serologic studies and attempts to isolate viruses and mycoplasmas from aspirated middle-ear fluids. N Engl J Med 1967; 277: 613-8.
61. Halsted C, Lepow ML, Balassanian N, Emmerich J, Wolinsky E. Otitis media: clinical observation, microbiology, and evaluation of therapy. Am J Dis Child 1968; 115: 542-51.
62. Sarkkinen HK, Meurman O, Salmi TT, Puhakka H, Virolainen E. Demonstration of viral antigens in middle ear secretions of children with acute otitis media. Acta Paediatr Scand 1983; 72: 137-8.
63. Chonmaitree T, Owen MJ, Howie VM. Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media. J Infect Dis 1990; 162: 546-9.
64. Chonmaitree T, Patel JA, Garofalo R, Uchida T, Sim T, Owen MJ, et al. Role of leukotriene B4 and interleukin-8 in acute bacterial and viral otitis media. Ann Otol Rhinol Laryngol 1996; 105: 968-74.
65. Okamoto Y, Kudo K, Ishikawa K, Ito E, Togawa K, Saito I, et al. Presence of respiratory syncytial virus genomic sequences in middle ear fluid and its relationship to expression of cytokines and cell adhesion molecules. J Infect Dis 1993; 168: 1277-81.
66. Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med 1999; 340: 260-4.
67. Teele DW, Pelton SI, Klein JO. Bacteriology of acute otitis media unresponsive to initial antimicrobial therapy. J Pediatr 1981; 98: 537-9.
68. Pichichero ME, Pichichero CL. Persistent acute otitis media: I. Causative pathogens. Pediatr Infect Dis J 1995; 14: 178-83.
69. Jossart GH, Canafax DM, Erdmann GR, Lovdahl MJ, Russlie HQ, Juhn SK, et al. Effect of Streptococcus pneumoniae and influenza A virus on middle ear anti-microbial pharmacokinetics in experimental otitis media. Pharm Res 1994; 11: 860-4.
70. Canafax DM, Yuan Z, Chonmaitree T, Deka K, Russlie HQ, Giebink GS. Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media. Pediatr Infect Dis J 1998; 17: 149-56.
71. Chonmaitree T, Patel JA, Lett-Brown MA, Uchida T, Garofalo R, Owen MJ, et al. Virus and bacteria enhance histamine production in middle ear fluids of children with acute otitis media. J Infect Dis 1994; 169: 1265-70.
72. Patel JA, Sim T, Owen MJ, Howie VM, Chonmaitree T. Influence of viral infection on middle ear chemokine response in acute otitis media. In: Lim DJ, Bluestone CD, Casselbrant M, Klein JO, Ogra PL, eds. Recent advances in otitis media. Hamilton, Canada: Decker; 1996: 178-9.
73. Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arola M, Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 1991; 145: 445-8.
74. Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6-to 30-month-old children in day care. Arch Pediatr Adolesc Med 1995; 149: 1113-7.
75. Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998; 338: 1405-12.
76. Ruohola A, Heikkinen T, Jero J, Puhakka T, Juvén T, Närkiö-Mäkelä M, et al. Oral prednisolone is an effective adjuvant therapy for acute otitis media with discharge through tympanostomy tubes. J Pediatr 1999; 134: 459-63.
77. Calfee DP, Hayden FG. New approaches to influenza chemotherapy: neuraminidase inhibitors. Drugs 1998; 56: 537-53.
78. Pevear DC, Tull TM, Seipel ME, Groarke JM. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother 1999; 43: 2109-15.